Part identity
2B0062P
Dextrose Injection
Baxter Healthcare Corporation
Avg quote: 14 minFulfilled from Anaheim, CAAS9120:2025 · ISO 9001 · FAA AC 00-56BC of C, lot & date code with every line
Part description
Dextrose Injection
ASAP supports this specific part for replacement, spare-pool replenishment, retrofit, and urgent maintenance requirements. Quote requests can include alternate MPN, condition preferences, certification needs, and plant-specific receiving instructions so procurement gets a clear sourcing response before purchase.
Specifications
Certifications & documentation
- UL Recognized
- CE
- C of C available on request
BH
Manufacturer
Baxter Healthcare Corporation
Authorized-distributor or qualified-aftermarket source. Parts shipped from this manufacturer include full traceability paperwork and counterfeit-mitigation per SAE AS6081.
View manufacturer profile →Characteristics Data of NSN 6505-01-182-8009, 6505011828009
| MRC | Criteria | Characteristic |
|---|---|---|
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 5.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT |
| AKJQ | PHARMACEUTICAL VEHICLE TYPE | AQUEOUS |
| CBBL | FEATURES PROVIDED | STERILE |
| CQCT | PRIMARY CONTAINER TYPE | BAG, PLASTIC |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 250.000 MILLILITERS |
| CSCW | TOTAL PRIMARY CONTAINER QUANTITY | 24 |
| CXCY | III PART NAME ASSIGNED BY CONTROLLING AGENCY | DEXTROSE INJECTION USP 5% 250ML PLASTIC BAG 24S |
| FEAT | SPECIAL FEATURES | WITH OVERPOUCH AS WATER VAPOR BARRIER; VIAFLEX CONTAINER. |
| MDES | MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| SUPP | III SUPPLEMENTARY FEATURES | D-DAY ITEM FOR DOD |